ISSN 2490-3329 (Print)
ISSN 2303-7954 (Online)

Volume 49, Issue 1, Article 7

(Scr Med 2018:49:43-48)
ORIGINAL ARTICLE

Testicular Tumors – Occurrence of Retroperitoneal Lymphadenomegaly at the Time of Diagnosis

Branislava Jakovljević1, Siniša Maksimović2, Snježana Milićević3, Dejan Đokanović4

1 Hospital for Surgical and Internal Medicine “S.tetik”– Oncology Department, Banja Luka, Bosnia and Herzegovina
2 General Hospital “Sveti Vračevi”, Bijeljina, Bosnia and Herzegovina
3 University Clinical Centre of Republika Srpska, Urology Clinic, Banja Luka, Bosnia and Herzegovina
4 University Clinical Centre of the Republic of Srpska, Oncology Clinic, Banja Luka, Bosnia and Herzegovina


doi: 10.18575/msrs.sm.e.18.07
UDC: 616.683-006-033.2
COBISS.RS-ID:7317784


ABSTRACT

Introduction: Testicular tumors account for approximately 1% of all malignancies in men, but the age of patients and its increasing incidence make this malignancy one of the leading oncological problems. In spite of the fact that the testicles are organs accessible for self-examination and the accessibility of ultrasound examination as the method of choice in diagnostics, these tumors are often detected in an advanced stage of the disease.

Aim of the Study: The aim of this study is to evaluate the occurrence of advanced disease at the time of diagnosis of testicular germ cell tumors, through retrospective analysis.

Patients and Methods: Our study examines patients with testicular germ cell tumor (seminomatous and non-seminomatous) according to numerous parameters – anamnesis with special emphasis on risk factors, clinical examination, laboratory analyses with tumor markers, and diagnostic imaging examinations (thorax, abdomen and pelvis CT scan). Before the specific treatment, spermiogram and semen cryopreservation were done for most patients, while in some cases additional diagnostics (MRI of the endocranium, skeletal scintigraphy) was indicated as well.

Results: During the observation period, 132 patients with testicular germ cell tumor were treated and observed, of which 58 patients (44%) with seminomatous tumor type and 74 patients (56%) with non-seminomatous tumors. Of the total number of patients, at the time of disease diagnosis, there were 41 patients (31%) with N1-N3 status of retroperitoneal lymph nodes and 17 patients (12.8%) with M1a-M1b metastatic status.

Conclusion: A large number of newly detected testicular tumors are diagnosed in an advanced stage of the disease. It is necessary to raise awareness of the general population about this malignancy, emphasise the importance of self-examination in younger men, and promote the possibility of routine ultrasound examinations with the aim of early detection of the disease.

Key words: testicular germ cell tumor, advanced disease


Pdf version of article


Reference
1. Curado M.P. et al. Cancer incidence in five continents, Vol IX. IARC Scientific Publication 2007, No. 160. http://www.iarc.fr/en/publications/pdfs-online/epi/index.php
2. Nigam M, Aschebrook-Kilfoy B, Shikanov S, Eggener S. Increasing incidence of testicular cancer in the United States and Europe between 1992 and 2009. World J Urol. 2015 May;33(5):623-31. https://doi.org/10.1007/s00345-014-1361-y  PMid:25030752    
3.Institut za javno zdravstvo Republike Srpske,Registar za rak Republike Srpske, www.phi.rs.ba    
4.Purdue MP, Devesa SS, Sigurdson AJ, McGlynn KA. International patterns and trends in testis cancer incidence. Int J Cancer 2005; 115:822-7. https://doi.org/10.1002/ijc.20931  PMid:15704170    
5.Hemminki K, Chen B.Familial risks in testicular cancer as aetiological clues. Int J Androl 2006;29:205-10. https://doi.org/10.1111/j.1365-2605.2005.00599.x  PMid:16466541    
6. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, Horwich A, Laguna MP, Nicolai N, Oldenburg J. EAU Guidelines on Testicular Cancer, European Association of Urology, 2016.   
7. Manecksha RP, Fitzpatrick JM. Epidemiology of testicular cancer. BJU Int. 2009 Nov; 104: 1329-33. https://doi.org/10.1111/j.1464-410X.2009.08854.x  PMid:19840008    
8. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, Horwich A, Laguna MP, Nicolai N, Oldenburg J. Guidelines on Testicular Cancer, European Association of Urology 2015.   
9. www.cancer.net/cancer-types/testicular-cancer/statistics
10. Albers P, Melchior D, Müller SC. Surgery in Metastatic Testicular Cancer,European Urology,2003; Vol 44, Issue 2, 233–244.
https://doi.org/10.1016/S0302-2838(03)00252-5
11. Gillessen S, Powles T, Lim L,Wilson P,Shamash J. Low-dose induction chemotherapy with Baby-BOP in patients with metastatic germ-cell tumours does not compromise outcome: a single-centre experience, Annals of Oncoloogy 21:2010;1589-93. https://doi.org/10.1093/annonc/mdq019  PMid:20164149    
12.Oldenburg J, Fosså S, Nuver J, Heidenreich A, Schmoll HJ, Bokemeyer C, Horwich A, Beyer J, Kataja V. Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 24 (Supplement 6): vi125–vi132, 2013. https://doi.org/10.1093/annonc/mdt304  PMid:24078656    
13. Chung PW, Gospodarowicz MK, Panzarella T, Jewett MA, Sturgeon JF, Tew-George B, Bayley AJ, Catton CN, Milosevic MF, Moore M, Warde PR. Stage II testicular seminoma: patterns of recurrence and outcome of treatment. Eur Urol. 2004 Jun; 45(6):754-59. https://doi.org/10.1016/j.eururo.2004.01.020  PMid:15149748    

Contact address:
Branislava Jakovljević
Hospital for Surgical and Internal
Medicine “S.tetik”
Street address:
Arsenija Čarnojevića 2
78000 Banja Luka,
Republic of Srpska
Bosnia and Herzegovina
e-mail:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
phone number: +387-65-876-102

Sumbitted: March 19th, 2018
Accepted: April 2nd, 2018